//=time() ?>
Systems to license, recommend or fund vaccines vary a lot in the EU. This diversity delays market access to new and innovative vaccines. What to do?
@JordanCollver , @owenwattsdraws @MSDInvents and Transmissible show you: https://t.co/RodrBVWfTN
Research and Development are the cornerstones of vaccine development for future threats. How to create a sustainable policy to foster innovation in this area?
@JordanCollver, @MSDInvents and Transmissible show you how: https://t.co/lGdGifyebT
Public health policies in the EU continue to be shaped by treaties, regulations, agencies, networks, and coalitions. Understanding coalitions is helpful in policymaking.
@JordanCollver, @MSDInvents and Transmissible show you how: https://t.co/lGdGifyebT
Childhood #vaccination versus #lifecourse. What are the #policy perspectives? Like most prevention: an ounce is more valuable than a pound of cure.
@JordanCollver, @MSDInvents and Transmissible show you: https://t.co/lGdGifyebT
#Outbreaks are special #publichealth situations where #vaccines can help control disease spread. This challenges supply and access. How to incorporate this perspective in #vaccination #policy?
@JordanCollver, @MSDInvents and Transmissible show you how: https://t.co/lGdGifyebT